+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
Diagnostic Enzyme Market Report 2025 - Product Thumbnail Image

Diagnostic Enzyme Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

Phosphatidylinositol 3-Kinase (PI3K) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
From
Gynecological Cancer Drugs Market Report 2025 - Product Thumbnail Image

Gynecological Cancer Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Ayvakit Patent, Sales & Clinical Trials Insight 2028 - Product Thumbnail Image

Ayvakit Patent, Sales & Clinical Trials Insight 2028

  • Report
  • October 2021
  • 85 Pages
  • Global
From
From
Autologous Cell Therapy Market Report 2025 - Product Thumbnail Image

Autologous Cell Therapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
From
From
From
CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Loading Indicator